- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04578275
Atrial Fibrillation Stratification Based on the Arrhythmia Perpetuation Mechanisms
STRATIFY TRIAL: Atrial Fibrillation Stratification Based on the Arrhythmia Perpetuation Mechanisms.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The MAIN GOAL of this project is to clinically validate the technology for the noninvasive identification of the mechanisms responsible for maintenance of AF using ECGI. To achieve this goal, the investigators will analyze the efficacy of different treatment options in persistent AF patients as a function of the results of the ECGI. Mainly, patients will be evaluated attending to the complexity of the patterns obtained. Moreover, the investigators will evaluate the treatment benefit of performing guided-ablation in conjunction with pulmonary vein isolation as compared to pulmonary vein isolation only. These analyses will be performed in patients with persistent AF arriving at the clinic to determine treatment options. AF outcomes following the treatment assigned therapy will be evaluated at 6 months and 1 year after.
These parameters are obtained from the ECGI map: histogram of rotors (number of rotors and location), Highest and Lowest Dominant Frequency (Hz), rotor duration (ms), simultaneous rotors (number of rotors) and signal entropy (normalized).
Wide antrum circumferential pulmonary vein isolation with demonstration of bidirectional block will be performed using standard cooled-tip radiofrequency catheters or cryoballoon catheters.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28007
- Hospital General Universitario Gregorio Maranon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with paroxysmal AF symptomatic and refractory to at least one antiarrhythmic medication arriving in atrial fibrillation to the AF clinic.
- Patients with paroxysmal AF undergoing AF ablation in whom AF was induced at the EP laboratory.
- Patients with persistent AF or long-term persistent AF attending the AF clinic.
- Patients must be able and willing to provide written informed consent to participate in the study.
- Prior anticoagulation for> 4 weeks or transesophageal echocardiogram excluding intracardiac thrombi.
Exclusion Criteria:
Inclusion Criteria:
- Patients with paroxysmal AF symptomatic and refractory to at least one antiarrhythmic medication arriving in atrial fibrillation to the AF clinic.
- Patients with paroxysmal AF undergoing AF ablation in whom AF was induced at the EP laboratory.
- Patients with persistent AF or long-term persistent AF attending the AF clinic.
- Patients must be able and willing to provide written informed consent to participate in the study.
- Prior anticoagulation for> 4 weeks or transesophageal echocardiogram excluding intracardiac thrombi.
Exclusion Criteria:
- Patients with inadequate anticoagulation levels, left atrial thrombus, tumor, or another abnormality which precludes catheter introduction on TEE prior to the procedure.
- Patients with moderate-to-severe mitral regurgitation.
- Patients with contraindications to systemic anticoagulation with heparin or coumadin.
- Patients who are or may potentially be pregnant.
- Current enrollment in another investigational drug or device study.
- Pacemaker or Implantable Cardioverter Defibrillator.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ECGI calculation of frecuency maps(Hz)
Time Frame: 12 months post-first intervention
|
Freedom from atrial fibrillation treated according to the ESC/AHA Atrial Fibrillation Guidelines in relation to the ECGI AF complexity score
|
12 months post-first intervention
|
ECGI calculation of frecuency of rotor maps
Time Frame: 12 months post-first intervention
|
number of rotors mesasured Atrial Fibrillation Guidelines in relation to the ECGI AF complexity score
|
12 months post-first intervention
|
ECGI AF complexity score calculated from the results of 1 and 2 to evaluate AF freedom from atrial fibrilation
Time Frame: 12 months post-first intervention
|
score calculated from the results of 1 and 2 to evaluate AF freedom from atrial fibrilation Atrial Fibrillation Guidelines in relation to the ECGI AF complexity score
|
12 months post-first intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Freedom from atrial fibrillation treated according to the ESC/AHA atrial fibrillation Guidelines evaluated in binary(0:AF Freedom;1:AF)
Time Frame: 12 months post-first intervention
|
12 months post-first intervention
|
|
Freedom from atrial fibrillation in patients undergoing rhythm control drug treatment.
Time Frame: at 6 and 12 months
|
at 6 and 12 months
|
|
Freedom from atrial fibrillation and other atrial arrhythmias in patients undergoing surgical AF ablation.
Time Frame: at 6 and 12 months
|
at 6 and 12 months
|
|
ECGI calculations of Highest Dominant Frecuency(Hz)
Time Frame: during ablation procedure and 12 months after
|
during ablation procedure and 12 months after
|
|
ECGI calculations of Lowest Dominant Frecuency(Hz)
Time Frame: during ablation procedure and 12 months after
|
during ablation procedure and 12 months after
|
|
ECGI calculations of Rotor duration from rotor maps(ms)
Time Frame: during ablation procedure and 12 months after
|
during ablation procedure and 12 months after
|
|
ECGI calculations of simultaneus number of rotors from rotor maps(ms)
Time Frame: during ablation procedure and 12 months after
|
during ablation procedure and 12 months after
|
|
Ablation procedure duration
Time Frame: Duration of ablation procedure
|
Duration of ablation procedure
|
|
Electrophysiological characteristics of the Atrial fibrillation complexity
Time Frame: Inclusion, rhythm vs rate treatment, ablation
|
Atrial fibrillation characteristics will be assesed according to the parameters obtained from ECGi calculations.
These parameters are obtained from the frecuency maps(Hz) and histogram of rotors(number of rotors and location) and include : Highest and Lowest Dominant Frecuency(Hz), rotor duration(ms) and simultaneous rotors(number of rotors)
|
Inclusion, rhythm vs rate treatment, ablation
|
Electroanatomic reconstruction and recordings of electrical activity
Time Frame: During ablation procedure
|
a three-dimensional reconstruction of atrium and coronary sinus is obtained using high density catheters and an electroanatomic navigation system.
|
During ablation procedure
|
Fluoroscopy time
Time Frame: During ablation procedure, in minutes
|
During ablation procedure, in minutes
|
|
Trained Neural Network based on ECGI signals
Time Frame: 6 and 12 month post-ablation outcome prediction
|
6 and 12 month post-ablation outcome prediction
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STRATIFY-AF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
St. George's Hospital, LondonRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited Kingdom
-
R-PharmFSBI "National Medical Research Center of Cardiology named after academician...CompletedAtrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationRussian Federation
Clinical Trials on diagnostic strategy using ECGI
-
Tianjin Chest HospitalRecruiting
-
Tongji HospitalUnknownFever of Unknown OriginChina
-
UMC UtrechtZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedHeart Failure | Chronic Obstructive Pulmonary DiseaseNetherlands
-
Aarhus University Hospital SkejbyMedis Medical Imaging SystemsActive, not recruitingCoronary Artery DiseaseSpain, Denmark, Sweden, Italy, Lithuania, Netherlands, Germany, France, Latvia, Poland, Switzerland
-
National Institute of Cardiology, Warsaw, PolandRecruitingCoronary Artery Disease | Total Occlusion of Coronary ArterySpain, France, Hungary, Czechia, Poland, Austria, Croatia, Germany, Israel, Italy, Romania
-
Royal Devon and Exeter NHS Foundation TrustTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedPulmonary EmbolismFrance, Spain
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Centre Hospitalier Universitaire de NīmesRecruitingStroke | Atrial Fibrillation | Deep Vein ThrombosisFrance